Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-21 20:26:58 UTC |
---|
Update Date | 2014-12-24 20:25:51 UTC |
---|
Accession Number | T3D2800 |
---|
Identification |
---|
Common Name | Quinine |
---|
Class | Small Molecule |
---|
Description | Quinine is an alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. |
---|
Compound Type | - Amine
- Analgesic, Non-Narcotic
- Antimalarial
- Drug
- Ether
- Food Toxin
- Metabolite
- Muscle Relaxant, Central
- Natural Compound
- Organic Compound
- Plant Toxin
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | (-)-Quinine | (8S,9R)-Quinine | (R)-(-)-Quinine | (R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol | 6'-Methoxycinchonidine | 6'-Methoxycinchonine | Chinin | Chinine | Chininum | Cinkona | Jasoquin | QSM | QUALAQUIN | Quinina | Quinine sulfate | Quinine sulphate | Quinine, Anhydrous | Quinineanhydrous | Quinlup | Quinoline Alkaloid | Qutil | Sulquin |
|
---|
Chemical Formula | C20H24N2O2 |
---|
Average Molecular Mass | 324.417 g/mol |
---|
Monoisotopic Mass | 324.184 g/mol |
---|
CAS Registry Number | 130-95-0 |
---|
IUPAC Name | (R)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol |
---|
Traditional Name | quinine |
---|
SMILES | [H][C@@](O)(C1=C2C=C(OC)C=CC2=NC=C1)[C@]1([H])C[C@]2([H])CCN1C[C@]2([H])C=C |
---|
InChI Identifier | InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1 |
---|
InChI Key | InChIKey=LOUPRKONTZGTKE-WZBLMQSHSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as cinchona alkaloids. These are alkaloids structurally characterized by the presence of the cinchonan skeleton, which consists of a quinoline linked to an azabicyclo[2.2.2]octane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Cinchona alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Cinchona alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Cinchonan-skeleton
- 4-quinolinemethanol
- Quinoline
- Anisole
- Quinuclidine
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Pyridine
- Benzenoid
- Heteroaromatic compound
- 1,2-aminoalcohol
- Tertiary aliphatic amine
- Tertiary amine
- Secondary alcohol
- Ether
- Azacycle
- Organoheterocyclic compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Amine
- Alcohol
- Organic oxygen compound
- Aromatic alcohol
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 57°C | Boiling Point | Not Available | Solubility | 500 mg/L (at 15°C) | LogP | 3.44 |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4r-1901000000-8176add5a84f7ae1eb69 | 2017-09-01 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (1 TMS) - 70eV, Positive | splash10-05g0-7947000000-ee233460f7e7fbb00ca7 | 2017-10-06 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 60V, Positive | splash10-00ai-7930000000-eb63f68d11153566b027 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 75V, Positive | splash10-00c0-7910000000-c0d16dda8d8a74dd1657 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 45V, Positive | splash10-0059-5945000000-dff1a74853685996f965 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 15V, Positive | splash10-004i-0009000000-4cf6c66b2059468cd1e3 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-004i-0009000000-d4367d77a81731ba3654 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 60V, Positive | splash10-00ai-7930000000-94e16a407d113a547240 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 45V, Positive | splash10-0059-5945000000-ddc4f19918fbae8ffe0c | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 90V, Positive | splash10-0fc0-6900000000-8bb456f41e7cb82dfcf9 | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 90V, Positive | splash10-0fc0-6900000000-f458cccf839df1d5239b | 2021-09-20 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 75V, Positive | splash10-00c0-7910000000-4b620f5ca762298602e7 | 2021-09-20 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a6r-0019000000-0f42379f2989cf204f72 | 2016-08-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4r-0729000000-5a0d8aa890e6c737bf45 | 2016-08-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0079-0920000000-70e4fed1a61c38cf53fb | 2016-08-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-0109000000-e84ce15e838ff8ac33f6 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-05fr-0229000000-b87ca7a53d952af7505e | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0540-0920000000-12d8977ce43e168f8453 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-004i-0009000000-2125f5c1412244f91fb3 | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-004i-0109000000-1096d980c779fca1eb3f | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-00dr-0920000000-468db2e8e8941541468c | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-00di-0019000000-9c5f7ffbd0d69038e6da | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0abi-0914000000-92707d10764c62ebe320 | 2021-09-24 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0a4i-0900000000-9e1ce60a980eb9551f33 | 2021-09-24 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral |
---|
Mechanism of Toxicity | The theorized mechanism of action for quinine and related anti-malarial drugs is that these drugs are toxic to the malaria parasite. Specifically, the drugs interfere with the parasite's ability to break down and digest hemoglobin. Consequently, the parasite starves and/or builds up toxic levels of partially degraded hemoglobin in itself. |
---|
Metabolism | Hepatic, over 80% metabolized by the liver.
Route of Elimination: Quinine is eliminated primarily via hepatic biotransformation. Approximately 20% of quinine is excreted unchanged in urine.
Half Life: Approximately 18 hours |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | For the treatment of malaria and leg cramps. Used as an antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory. It is also used as a flavor component of tonic water and bitter lemon. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | It is usual for quinine in therapeutic doses to cause cinchonism; in rare cases, it may even cause death (usually by pulmonary edema). Quinine can worsen hemoglobinuria, myasthenia gravis and optic neuritis. It can cause paralysis if accidentally injected into a nerve, and is extremely toxic in overdose[Wikipedia] |
---|
Symptoms | Fever, rarely hypotension. [wikipedia] |
---|
Treatment | Not Available |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB00468 |
---|
HMDB ID | HMDB14611 |
---|
PubChem Compound ID | 3034034 |
---|
ChEMBL ID | CHEMBL387326 |
---|
ChemSpider ID | 84989 |
---|
KEGG ID | C06526 |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 15854 |
---|
BioCyc ID | 3-HYDROXYQUININE |
---|
CTD ID | Not Available |
---|
Stitch ID | Quinine |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Quinine |
---|
References |
---|
Synthesis Reference | Tong Sun, Shawn Watson, Wei Lai, Stephan D. Parent, “QUININE SULFATE/BISULFATE SOLID COMPLEX; METHODS OF MAKING; AND METHODS OF USE THEREOF.” U.S. Patent US20090326005, issued December 31, 2009. |
---|
MSDS | Link |
---|
General References | - Paintaud G, Alvan G, Berninger E, Gustafsson LL, Idrizbegovic E, Karlsson KK, Wakelkamp M: The concentration-effect relationship of quinine-induced hearing impairment. Clin Pharmacol Ther. 1994 Mar;55(3):317-23. [8143397 ]
- Drugs.com [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Gene | Gene Symbol | Gene ID | Interaction | Chromosome | Details |
---|
|
---|
Down-Regulated Genes | Not Available |
---|